A Diagnostic Approach to Pruritus



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2011 Jul 15;84(2):195-202.

  Patient information: See related handout on pruritus, written by the authors of this article.

  Related letters: Responses to Article Regarding a Diagnostic Approach to Pruritus

Pruritus can be a symptom of a distinct dermatologic condition or of an occult underlying systemic disease. Of the patients referred to a dermatologist for generalized pruritus with no apparent primary cutaneous cause, 14 to 24 percent have a systemic etiology. In the absence of a primary skin lesion, the review of systems should include evaluation for thyroid disorders, lymphoma, kidney and liver diseases, and diabetes mellitus. Findings suggestive of less serious etiologies include younger age, localized symptoms, acute onset, involvement limited to exposed areas, and a clear association with a sick contact or recent travel. Chronic or generalized pruritus, older age, and abnormal physical findings should increase concern for underlying systemic conditions. Initial evaluation for systemic disease includes complete blood count and measurement of thyroid-stimulating hormone, fasting glucose, alkaline phosphatase, bilirubin, creatinine, and blood urea nitrogen. Hodgkin lymphoma is the malignant disease most strongly associated with pruritus, which affects up to 30 percent of patients with the disease. Chest radiography is needed when lymphoma is suspected. A wheal and flare response indicates histamine-induced pruritus in patients with urticaria or an allergic dermatitis. These patients benefit from continuous dosing of a long-acting antihistamine. Second-generation antihistamines, such as cetirizine, loratadine, and fexofenadine, may be more effective because of improved patient compliance.

Pruritus is the subjective sensation of itching. It can become severe enough to interfere with work and restful sleep. Histamine is the primary mediator of itching in many disorders.1 Antihistamines are effective in treating histamine-mediated pruritus, but they may be less effective in patients with diseases that trigger pruritus through mechanisms involving serotonin, leukotrienes, or neuropeptides.1,2

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendations Evidence rating References

If there is diagnostic uncertainty in patients with pruritus, initial evaluation for systemic disease should include thyroid-stimulating hormone, fasting glucose, alkaline phosphatase, bilirubin, creatinine, and blood urea nitrogen levels; complete blood count; and human immunodeficiency virus antibody assay.

C

68

First-and second-generation antihistamines are equally effective for resolution of pruritus.

B

39


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

View Table

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendations Evidence rating References

If there is diagnostic uncertainty in patients with pruritus, initial evaluation for systemic disease should include thyroid-stimulating hormone, fasting glucose, alkaline phosphatase, bilirubin, creatinine, and blood urea nitrogen levels; complete blood count; and human immunodeficiency virus antibody assay.

C

68

First-and second-generation antihistamines are equally effective for resolution of pruritus.

B

39


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.

Evaluation

The initial clinical approach in patients with pruritus includes a history and physical examination to determine if the pruritus is caused by a dermatologic condition or is secondary to an underlying systemic disease. Figure 1 is a diagnostic algorithm for pruritus.

Diagnosing the Cause of Pruritus

Figure 1.

Diagnostic algorithm for pruritus.

View Large

Diagnosing the Cause of Pruritus


Figure 1.

Diagnostic algorithm for pruritus.

Diagnosing the Cause of Pruritus


Figure 1.

Diagnostic algorithm for pruritus.

The presence of a primary skin lesion may aim the evaluation toward a dermatologic cause. The history should focus on recent exposures to new topical, oral, or airborne substances that can cause skin lesions. New cosmetics and creams can trigger allergic contact dermatitis, urticaria, and photodermatitis. New drugs (medications, nutritional supplements, illicit drugs) can lead to urticaria or fixed drug eruptions. Travel can expose a person to new foods that can trigger urticaria and to sunlight that can trigger photodermatitis. Travelers are also susceptible to infestations, such as with scabies or lice. Hobbies may expose the skin to solvents and topical agents that can trigger contact dermatitis. Chronic occupational exposure to solvents can dry the skin, causing xerosis and atopic dermatitis or eczema. New animal exposures can lead to flea infestations, allergic cutaneous reactions to dander, and urticaria. Another important finding in the evaluation of patients with pruritus is a recent exposure to sick contacts who have febrile diseases, such as rubeola, mumps, or varicella, or exposure to infectious organisms that can cause rashes, such as parvovirus, Staphylococcus aureus, or Streptococcus species. In the absence of a primary skin lesion, the review of systems should include evaluation for thyroid disorders, lymphoma, kidney and liver diseases, and diabetes mellitus. Table 1 includes historical findings that suggest etiologies for pruritus.

Table 1.

Historical Findings That Suggest Etiologies for Pruritus

Historical finding Possible etiologies

New cosmetics or creams

Allergic contact dermatitis, urticaria, photodermatitis

New medications, supplements, or illicit drugs

Urticaria, fixed drug eruptions

Recent travel

Pediculosis, scabies infestation, photodermatitis, urticaria

Hobby or occupational exposure to solvents, adhesives, cleaners

Irritant contact dermatitis, xerosis, atopic dermatitis, eczema

New animal exposures

Flea infestation, allergic contact dermatitis, urticaria

Sick contacts, especially those with febrile diseases and rashes

Rubeola, mumps, varicella, scarlet fever, cellulitis, fifth disease, folliculitis

Unexplained weight changes, menstrual irregularity, heat/cold intolerance

Thyroid disease with secondary urticaria or xerosis

Unexplained weight loss, night sweats, unexplained fevers, fatigue

Lymphoma with secondary generalized pruritus

Malaise, nausea, decreased urine output

Renal failure with generalized pruritus

Table 1.   Historical Findings That Suggest Etiologies for Pruritus

View Table

Table 1.

Historical Findings That Suggest Etiologies for Pruritus

Historical finding Possible etiologies

New cosmetics or creams

Allergic contact dermatitis, urticaria, photodermatitis

New medications, supplements, or illicit drugs

Urticaria, fixed drug eruptions

Recent travel

Pediculosis, scabies infestation, photodermatitis, urticaria

Hobby or occupational exposure to solvents, adhesives, cleaners

Irritant contact dermatitis, xerosis, atopic dermatitis, eczema

New animal exposures

Flea infestation, allergic contact dermatitis, urticaria

Sick contacts, especially those with febrile diseases and rashes

Rubeola, mumps, varicella, scarlet fever, cellulitis, fifth disease, folliculitis

Unexplained weight changes, menstrual irregularity, heat/cold intolerance

Thyroid disease with secondary urticaria or xerosis

Unexplained weight loss, night sweats, unexplained fevers, fatigue

Lymphoma with secondary generalized pruritus

Malaise, nausea, decreased urine output

Renal failure with generalized pruritus

Physical examination should include an evaluation of the liver, spleen, and lymph nodes. Organomegaly increases the likelihood of an underlying systemic disease, such as lymphoma. The skin should also be examined. Finger webs, intertriginous regions, and the genitals should be evaluated for the presence of scabies or lice.

Historical and physical findings that suggest a less serious etiology include younger age, localized symptoms, acute onset, involvement limited to exposed areas, and a clear association with a sick contact or recent travel.35 Chronic or generalized pruritus, age older than 65 years, and abnormal physical findings should increase concern for an underlying systemic condition.38

If the diagnosis is unclear after the history and physical examination or if initial empiric treatment is ineffective, a limited laboratory evaluation should be performed, including complete blood count and measurement of thyroid-stimulating hormone, fasting glucose, alkaline phosphatase, bilirubin, creatinine, and blood urea nitrogen. 5 If immune suppression or lymphoma is possible, a human immunodeficiency virus antibody assay and chest radiography should also be performed. 5-8 Further diagnostic tests may include biopsy, scraping, or culture of the skin or lesions.

Differential Diagnosis of Pruritus

Pruritus can be a symptom of a distinct dermatologic condition (Table 2 7) or of an occult underlying systemic disease (Table 32,3,5,7,9,10).

Table 2.

Dermatologic Etiologies for Pruritus

Etiology Features

Allergic/irritant contact dermatitis

Sharply demarcated, erythematous lesion with overlying vesicles

Reaction within two to seven days of exposure

Atopic dermatitis

Pruritic area where rash appears when scratched in patients with atopic conditions (e.g., allergic rhinitis, asthma)

Involvement of flexor wrists and ankles, as well as antecubital and popliteal fossae

Bullous pemphigoid

Initially pruritic urticarial lesions, often in intertriginous areas

Formation of tense blisters after urticaria

Cutaneous T-cell lymphoma (mycosis fungoides)

Oval eczematous patch on skin with no sun exposure (e.g., buttocks)

Possible presentation of new eczematous dermatitis in older adults

Possible presentation of erythroderma (exfoliative dermatitis)

Dermatitis herpetiformis

Rare vesicular dermatitis affecting the lumbosacral spine, elbows, or knees

Dermatophyte infection

Localized pruritus and rash characterized by peripheral scaling and central clearing

Can occur on several sites, including the feet, scalp, trunk, and groin

Folliculitis

Pruritus out of proportion to appearance of dermatitis

Papules and pustules at follicular sites on chest, back, or thigh

Lichen planus

Lesions often located on the flexor wrists

Characterized by the six P's (pruritus, polygonal, planar, purple, papules, plaques)

Lichen simplex chronicus

Localized, intense pruritus

Initial erythematous, well-defined plaques with excoriations lead to thickened, lichenified, violaceous patches if scratching continues

Pediculosis (lice infestation)

Occiput in school-aged children; genitalia in adults (sexually transmitted)

Psoriasis

Plaques on extensor extremities, low back, palms, soles, and scalp

Scabies

Burrows in hand web spaces, axillae, and genitalia

Hyperkeratotic plaques, pruritic papules or scales

Face and scalp affected in children but not in adults

Sunburn

Possible photosensitizing cause (e.g., with use of nonsteroidal anti-inflammatory drugs or cosmetics)

Urticaria (hives)

Intensely pruritic, well-circumscribed, erythematous, and elevated wheals

Lesions may coalesce and wax and wane over several hours

Xerosis

Intense pruritus, often during winter months in northern climates

Involvement of back, flank, abdomen, waist, and lower extremities

More common in older persons


Adapted with permission from Moses S. Pruritus. Am Fam Physician. 2003;68(6):1136.

Table 2.   Dermatologic Etiologies for Pruritus

View Table

Table 2.

Dermatologic Etiologies for Pruritus

Etiology Features

Allergic/irritant contact dermatitis

Sharply demarcated, erythematous lesion with overlying vesicles

Reaction within two to seven days of exposure

Atopic dermatitis

Pruritic area where rash appears when scratched in patients with atopic conditions (e.g., allergic rhinitis, asthma)

Involvement of flexor wrists and ankles, as well as antecubital and popliteal fossae

Bullous pemphigoid

Initially pruritic urticarial lesions, often in intertriginous areas

Formation of tense blisters after urticaria

Cutaneous T-cell lymphoma (mycosis fungoides)

Oval eczematous patch on skin with no sun exposure (e.g., buttocks)

Possible presentation of new eczematous dermatitis in older adults

Possible presentation of erythroderma (exfoliative dermatitis)

Dermatitis herpetiformis

Rare vesicular dermatitis affecting the lumbosacral spine, elbows, or knees

Dermatophyte infection

Localized pruritus and rash characterized by peripheral scaling and central clearing

Can occur on several sites, including the feet, scalp, trunk, and groin

Folliculitis

Pruritus out of proportion to appearance of dermatitis

Papules and pustules at follicular sites on chest, back, or thigh

Lichen planus

Lesions often located on the flexor wrists

Characterized by the six P's (pruritus, polygonal, planar, purple, papules, plaques)

Lichen simplex chronicus

Localized, intense pruritus

Initial erythematous, well-defined plaques with excoriations lead to thickened, lichenified, violaceous patches if scratching continues

Pediculosis (lice infestation)

Occiput in school-aged children; genitalia in adults (sexually transmitted)

Psoriasis

Plaques on extensor extremities, low back, palms, soles, and scalp

Scabies

Burrows in hand web spaces, axillae, and genitalia

Hyperkeratotic plaques, pruritic papules or scales

Face and scalp affected in children but not in adults

Sunburn

Possible photosensitizing cause (e.g., with use of nonsteroidal anti-inflammatory drugs or cosmetics)

Urticaria (hives)

Intensely pruritic, well-circumscribed, erythematous, and elevated wheals

Lesions may coalesce and wax and wane over several hours

Xerosis

Intense pruritus, often during winter months in northern climates

Involvement of back, flank, abdomen, waist, and lower extremities

More common in older persons


Adapted with permission from Moses S. Pruritus. Am Fam Physician. 2003;68(6):1136.

Table 3.

Systemic Etiologies for Pruritus

Autoimmune

Dermatitis herpetiformis

Dermatomyositis

Linear immunoglobulin A disease

Sjögren syndrome

Hematologic

Hemochromatosis

Iron deficiency anemia

Mastocytosis

Plasma cell dyscrasias

Polycythemia vera

Hepatobiliary

Biliary cirrhosis

Chronic pancreatitis with obstruction of biliary tracts

Drug-induced cholestasis

Hepatitis, particularly hepatitis C

Sclerosing cholangitis

Infectious disease

AIDS

Infectious hepatitis

Parasitic disease (giardiasis, onchocerciasis, schistosomiasis, ascariasis)

Prion disease

Malignancy

Leukemia

Lymphoma

Multiple myeloma

Solid tumors with paraneoplastic syndrome

Metabolic and endocrine

Carcinoid syndrome

Chronic renal disease

Diabetes mellitus

Hyper/hypothyroidism

Hyperparathyroidism

Neurologic

Cerebral abscess

Cerebral tumor

Multiple sclerosis

Stroke

Other

Drug ingestion

Eating disorders with rapid weight loss

Neuropsychiatric disorders

Pregnancy


Information from references 2, 3, 5, 7, 9, and 10.

Table 3.   Systemic Etiologies for Pruritus

View Table

Table 3.

Systemic Etiologies for Pruritus

Autoimmune

Dermatitis herpetiformis

Dermatomyositis

Linear immunoglobulin A disease

Sjögren syndrome

Hematologic

Hemochromatosis

Iron deficiency anemia

Mastocytosis

Plasma cell dyscrasias

Polycythemia vera

Hepatobiliary

Biliary cirrhosis

Chronic pancreatitis with obstruction of biliary tracts

Drug-induced cholestasis

Hepatitis, particularly hepatitis C

Sclerosing cholangitis

Infectious disease

AIDS

Infectious hepatitis

Parasitic disease (giardiasis, onchocerciasis, schistosomiasis, ascariasis)

Prion disease

Malignancy

Leukemia

Lymphoma

Multiple myeloma

Solid tumors with paraneoplastic syndrome

Metabolic and endocrine

Carcinoid syndrome

Chronic renal disease

Diabetes mellitus

Hyper/hypothyroidism

Hyperparathyroidism

Neurologic

Cerebral abscess

Cerebral tumor

Multiple sclerosis

Stroke

Other

Drug ingestion

Eating disorders with rapid weight loss

Neuropsychiatric disorders

Pregnancy


Information from references 2, 3, 5, 7, 9, and 10.

COMMON DERMATOLOGIC CAUSES

Atopic Dermatitis. Atopic dermatitis is characterized by pruritus. It is generally defined as a chronic, relapsing inflammatory skin disease that often occurs in patients with a personal or family history of asthma or allergic rhinitis. 11 In contrast to other dermatologic disorders, atopic dermatitis often lacks a primary skin lesion. Usually only the secondary cutaneous findings of excoriation, weeping, lichenification, and pigment changes are apparent.2

Contact Dermatitis. Contact dermatitis is a rash caused by direct skin exposure to a substance. It is one of the most common skin disorders, with a lifetime prevalence of 30 percent. 12 Often intensely pruritic, the dermatitis can be induced by an allergen or more commonly by an irritant. Irritant contact dermatitis represents the most common cause of occupational skin diseases in industrial countries.13

Dermatophytes. Dermatophyte infections cause localized pruritus and a rash characterized by peripheral scaling and central clearing. Tinea pedis (athlete's foot) usually occurs between the toes with dry, cracking skin and white areas of maceration. Tinea infections can occur at several other sites, including the scalp, trunk, and groin.

Lice. Pediculosis is marked by pruritus caused by a delayed hypersensitivity reaction to the saliva of the louse. A magnifying lens is often necessary to see the lice or eggs, usually at the base of hair shafts. Body lice are typically found in patients with poor hygiene, whereas pubic lice are sexually transmitted.14

Lichen Simplex Chronicus. Lichen simplex chronicus is a localized disorder characterized by pruritus that leads to thickened, lichenified, violaceous patches. These patches are intensely pruritic, which causes the patient to continue to scratch, perpetuating the cycle. Early lesions manifest as erythematous, well-defined plaques with excoriations. Lesions continue to thicken if the itch-scratch-itch cycle is not broken with appropriate treatment.15

Psoriasis. Up to 80 percent of patients with psoriasis report pruritus that is cyclical, with nocturnal exacerbations that interrupt sleep. Pruritus is often more generalized and not restricted to areas of psoriatic plaques.16

Scabies. The classic feature of scabies is pruritus, which is caused by deposition of mite eggs in the epidermal layer of skin. The pruritus is often severe and worsens at night.

The primary lesion is a small, erythematous papule that is often excoriated. A thin, reddish-brown line, or burrow, 2 to 15 mm long in intertriginous regions is more pathognomic. However, burrows are often absent or obscured by excoriation or secondary infection. 17

Urticaria. Urticaria, or hives, is a common disorder that affects up to 25 percent of the population.18 The usual lesion is an intensely pruritic, well-circumscribed, erythematous, elevated wheal. Individual lesions may coalesce and wax and wane over several hours.19 Histamine is the primary mediator for most types of urticaria, although other immunohistochemicals may play an important role in more chronic cases.18

Xerosis. Xerosis is the most common cause of pruritus in the absence of an identifiable skin lesion. It is characterized by dry, scaly skin, usually on the lower extremities and in axillary creases, and most often occurs in the winter months. Associated factors include older age, frequent bathing, use of hot water when bathing, and exposure to high ambient temperatures with relatively low humidity.20

COMMON SYSTEMIC CAUSES

Pruritus in the absence of a primary dermatologic etiology may be indicative of a serious underlying systemic disease. 4 Studies have shown that 14 to 24 percent of patients presenting to a dermatologist's office with pruritus and no primary dermatologic cause have a systemic condition. 4,9,2124 However, pruritus is often overemphasized as an early manifestation of cancer.4,21

Chronic Renal Disease. More than 50 percent of patients with chronic renal disease and up to 80 percent of patients on dialysis have pruritus.2 The pruritus is often generalized, but may be localized to the back.25

Liver Disease. Pruritus caused by impaired bile secretion is a common symptom in several forms of liver disease. It can be generalized, but is typically worse on the palms and soles. Associated conditions include primary biliary cirrhosis, sclerosing cholangitis, viral hepatitis, drug-induced cholestasis, and other causes of obstructive jaundice. Biliary obstruction leads to pruritus in these disorders, but there is little correlation between serum bilirubin level and severity of pruritus.26

Malignancy. The possibility of an underlying malignant disease should be considered in patients with generalized pruritus of unknown cause. Among malignant diseases, Hodgkin lymphoma has the strongest association with pruritus, which occurs in up to 30 percent of patients with the disease.10 Pruritus can precede the clinical presentation of lymphoma by up to five years and is often the presenting symptom.5 Pruritus has been reported as a paraneoplastic manifestation in patients with nasopharynx, prostate, stomach, breast, brain, uterine, or colon cancer.5,27

Peripheral or Central Nervous System. Pruritus can also arise from diseases or disorders of the peripheral or central nervous system, such as multiple sclerosis, neuropathy, and nerve compression or irritation (e.g., notalgia paresthetica, brachioradial pruritus).28

Pregnancy. Pregnancy-related dermatoses (Table 4 17,2935 ) represent a heterogeneous group of pruritic inflammatory skin diseases related to pregnancy or the postpartum period. Some dermatoses cause only intense pruritus and skin lesions (e.g., polymorphic eruption of pregnancy, atopic eruption of pregnancy), but others can cause significant fetal risks, including prematurity, growth restriction, fetal distress, and intrauterine fetal demise (e.g., intrahepatic cholestasis of pregnancy, pemphigoid gestationis).2937 Early recognition, precise diagnosis, and prompt treatment are essential for improving maternal and fetal prognosis.

Table 4.

Pregnancy-Related Dermatoses That Cause Pruritus

Condition Synonyms Timing Features Important considerations Prognosis

Atopic eruption of pregnancy

Prurigo, early-onset prurigo, pruritic folliculitis, or eczema of pregnancy; prurigo gestationis

Second trimester (75 percent of patients affected before third trimester)

Two-thirds of patients have widespread eczematous changes, mainly on flexural sites1,2

One-third of patients have focal lesions; follicular, papular, or pustular

Generalized xerosis

Most common dermatosis in pregnancy

Affects patients with personal or family history of atopy5

Good maternal response to treatment

No fetal effects or lesions

New born at high risk of developing atopy

Tends to recur in subsequent pregnancies

Intrahepatic cholestasis of pregnancy1,2

Cholestasis of pregnancy, obstetric cholestasis, jaundice of pregnancy, pruritus gravidarum, prurigo gravidarum, icterus gravidarum

Third trimester

Sudden onset of intense pruritus

Often starts on palms or soles, then becomes generalized

Only secondary skin changes from scratching are apparent

Elevated total serum bile acid levels

Fetal risks include prematurity (19 to 60 percent), intrapartum fetal distress (22 to 33 percent), and fetal demise (1to 2 percent)6,7

Close monitoring with delivery after lungs mature reduces fetal risks

Maternal risks include steatorrhea with vitamin K deficiency and bleeding complications

Tends to recur in subsequent pregnancies

Pemphigoid gestationis

Herpes gestationis

Third trimester or postpartum

Intense pruritus precedes urticarial plaques or papules surrounding umbilicus

Spreads rapidly and forms bullae

Autoimmune disorder with increased lifetime risk of Graves disease

Skin biopsy is needed to confirm diagnosis

Risk of fetal growth restriction3

Antepartum fetal testing is warranted

Causes lesions in 10 percent of newborns

Tends to recur in subsequent pregnancies

Polymorphic eruption of pregnancy

Pruritic urticarial papules and plaques, polymorphic eruption, toxic erythema, toxemic rash, or late-onset prurigo of pregnancy

Late third trimester and postpartum, most often in primigravida

Mainly papulourticarial

Starts within striae, coalesces into plaques, and spreads to buttocks and proximal thighs; spares umbilical region

Occurs in one in 160 pregnancies4

Typically resolves within four to six weeks 5

Associated with excessive maternal weight gain and multiple gestation6

Excellent maternal and fetal prognoses

No cutaneous involvement in newborn

Does not tend to recur in subsequent pregnancies


Information from references 1 through 7, and 29 through 35.

Table 4.   Pregnancy-Related Dermatoses That Cause Pruritus

View Table

Table 4.

Pregnancy-Related Dermatoses That Cause Pruritus

Condition Synonyms Timing Features Important considerations Prognosis

Atopic eruption of pregnancy

Prurigo, early-onset prurigo, pruritic folliculitis, or eczema of pregnancy; prurigo gestationis

Second trimester (75 percent of patients affected before third trimester)

Two-thirds of patients have widespread eczematous changes, mainly on flexural sites1,2

One-third of patients have focal lesions; follicular, papular, or pustular

Generalized xerosis

Most common dermatosis in pregnancy

Affects patients with personal or family history of atopy5

Good maternal response to treatment

No fetal effects or lesions

New born at high risk of developing atopy

Tends to recur in subsequent pregnancies

Intrahepatic cholestasis of pregnancy1,2

Cholestasis of pregnancy, obstetric cholestasis, jaundice of pregnancy, pruritus gravidarum, prurigo gravidarum, icterus gravidarum

Third trimester

Sudden onset of intense pruritus

Often starts on palms or soles, then becomes generalized

Only secondary skin changes from scratching are apparent

Elevated total serum bile acid levels

Fetal risks include prematurity (19 to 60 percent), intrapartum fetal distress (22 to 33 percent), and fetal demise (1to 2 percent)6,7

Close monitoring with delivery after lungs mature reduces fetal risks

Maternal risks include steatorrhea with vitamin K deficiency and bleeding complications

Tends to recur in subsequent pregnancies

Pemphigoid gestationis

Herpes gestationis

Third trimester or postpartum

Intense pruritus precedes urticarial plaques or papules surrounding umbilicus

Spreads rapidly and forms bullae

Autoimmune disorder with increased lifetime risk of Graves disease

Skin biopsy is needed to confirm diagnosis

Risk of fetal growth restriction3

Antepartum fetal testing is warranted

Causes lesions in 10 percent of newborns

Tends to recur in subsequent pregnancies

Polymorphic eruption of pregnancy

Pruritic urticarial papules and plaques, polymorphic eruption, toxic erythema, toxemic rash, or late-onset prurigo of pregnancy

Late third trimester and postpartum, most often in primigravida

Mainly papulourticarial

Starts within striae, coalesces into plaques, and spreads to buttocks and proximal thighs; spares umbilical region

Occurs in one in 160 pregnancies4

Typically resolves within four to six weeks 5

Associated with excessive maternal weight gain and multiple gestation6

Excellent maternal and fetal prognoses

No cutaneous involvement in newborn

Does not tend to recur in subsequent pregnancies


Information from references 1 through 7, and 29 through 35.

Psychiatric Illness. Psychiatric illness can cause pruritus and is diagnosed through exclusion. Neurotic excoriations are scattered, linear, crusted lines that may occur anywhere on the body within reach of the patient, although they are most often confined to the extremities. They are associated with obsessive-compulsive disorder, depression, and delusions of parasitosis.38

Treatment

A wheal and flare response is a marker of histamine-induced pruritus in patients with urticaria or an allergic dermatitis. These patients benefit from continuous dosing of long-acting antihistamines. First-and second-generation antihistamines are equally effective for resolution of pruritus.39 However, second-generation antihistamines (e.g., cetirizine [Zyrtec], loratadine [Claritin], fexofenadine [Allegra]) cause fewer adverse effects, leading to improved patient compliance.2,40 Concurrent administration of histamine H1 and H2 blockers increases therapeutic effectiveness.2

Most patients with pruritus benefit from several basic measures to lessen drying of skin, which can increase symptoms. Bathing should be limited to short, cool showers with soap applied only to intertriginous or oily skin areas. A mild moisturizing cream should be applied immediately after bathing. The patient's home should be humidified to at least 40 percent, especially during dry, cold winter months. Contact irritants, such as wool, fiberglass, and detergents, irritate most skin and can exacerbate symptoms, particularly in persons with sensitivity to these agents.2,3,5,41,42

The conditions that can lead to pruritus are extensive. Distinguishing between pruritus with a specific dermatologic cause and pruritus that is a manifestation of a systemic disease can facilitate efficient diagnosis and treatment, leading to a rapid resolution of symptoms for most patients. Treatment options for specific etiologies of pruritus are beyond the scope of this article.

The Authors

BRIAN V. REAMY, MD, FAAFP, is a professor of family medicine and is the associate dean for faculty at the Uniformed Services University of the Health Sciences in Bethesda, Md.

CHRISTOPHER W. BUNT, MAJ, USAF, MC, is the predoctoral education coordinator and associate program director of the Ehrling Bergquist Family Medicine Residency Program at Offutt Air Force Base, Neb. He is also an assistant professor in the Department of Family Medicine at the Uniformed Services University of the Health Sciences and at the University of Nebraska Medical Center in Omaha.

STACY FLETCHER, CAPT, USAF, MC, is a staff physician in the Ehrling Bergquist Family Medicine Residency Program. She is also an assistant professor in the Department of Family Medicine at the University of Nebraska Medical Center.

Address correspondence to Brian V. Reamy, MD, FAAFP, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 21037 (e-mail: breamy@usuhs.mil). Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations to disclose.

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the U.S. Air Force Medical Department or the U.S. Air Force at large.

REFERENCES

1. Paus R, Schmelz M, Bíró T, et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116(5):1174–1186.

2. Charlesworth EN, Beltrani VS. Pruritic dermatoses: overview of etiology and therapy. Am J Med. 2002;113(suppl 9A):25S–33S.

3. Yosipovitch G, David M. The diagnostic and therapeutic approach to idiopathic generalized pruritus. Int J Dermatol. 1999;38(12):881–887.

4. Zirwas MJ, Seraly MP. Pruritus of unknown origin: a retrospective study. J Am Acad Dermatol. 2001;45(6):892–896.

5. Etter L, Myers SA. Pruritus in systemic disease: mechanisms and management Dermatol Clin. 2002;20(3):459–472, vi–vii.

6. Krajnik M, Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manage. 2001;21(2):151–168.

7. Moses S. Pruritus. Am Fam Physician. 2003;68(6):1135–1142.

8. Essential Evidence Plus. Trikha A, Ebell M. Pruritus. October 11, 2009. http://www.essentialevidenceplus.com (subscription required). Accessed April 25, 2011.

9. Kantor GR, Lookingbill DP. Generalized pruritus and systemic disease. J Am Acad Dermatol. 1983;9(3):375–382.

10. Lober CW. Should the patient with generalized pruritus be evaluated for malignancy? J Am Acad Dermatol. 1988;19(2 pt 1):350–352.

11. Charlesworth EN. Practical approaches to the treatment of atopic dermatitis. Allergy Proc. 1994;15(6):269–274.

12. Kadyk DL, McCarter K, Achen F. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol. 2003;49(6):1037–1048.

13. Clark SC, Zirwas MJ. Management of occupational dermatitis Dermatol Clin. 2009;27(3):365–383, vii–viii.

14. Greco PJ, Ende J. Pruritus: a practical approach. J Gen Intern Med. 1992;7(3):340–349.

15. Lichon V, Khachemoune A. Lichen simplex chronicus. Dermatol Nurs. 2007;19(3):276.

16. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280–284.

17. Andrews RM, McCarthy J, Carapetis JR, et al. Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am. 2009;56(6):1421–1440.

18. Gratten CEH, Charlesworth EN. Urticaria. In: Holgate ST, Lichtenstein LM, Church MK, eds. Allergy. 2nd ed. London, United Kingdom: Mosby; 2001: 93–104.

19. Charlesworth EN. The spectrum of urticaria. All that urticates may not be urticaria. Immunol Allergy Clin North Am. 1995;15(4):641–657.

20. Millikan LE. Treating pruritus. What's new in safe relief of symptoms? Postgrad Med. 1996;99(1):173–176.

21. Greaves MW. Itching—research has barely scratched the surface. N Engl J Med. 1992;326(15):1016–1017.

22. Rajka G. Investigation of patients suffering from generalized pruritus, with special references to systemic diseases. Acta Derm Venereol. 1966;46(2):190–194.

23. Lyell A. The itching patient. A review of the causes of pruritus. Scott Med J. 1972;17(10):334–337.

24. Beare JM. Generalized pruritus. A study of 43 cases. Clin Exp Dermatol. 1976;1(4):343–352.

25. Ponticelli C, Bencini PL. Pruritus in dialysis patients: a neglected problem. Nephrol Dial Transplant. 1995;10(12):2174–2176.

26. Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. JAMA. 1992;268(23):3359–3362.

27. Fleischer AB Jr. Pruritus in the elderly. Adv Dermatol. 1995;10:41–59.

28. Bernhard JD. Itch and pruritus: what are they, and how should itches be classified? Dermatol Ther. 2005;18(4):288–291.

29. Vaughan Jones SA, Hern S, Nelson-Piercy C, et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999;141(1):71–81.

30. Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, et al. The specific dermatoses of pregnancy revisited and reclassified. J Am Acad Dermatol. 2006;54(3):395–404.

31. Rudolph CM, Al-Fares S, Vaughan-Jones SA, et al. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol. 2006;154(1):54–60.

32. Black MM. Polymorphic eruption of pregnancy. In: Black MM, McKay M, Braude PR, et al., eds. Obstetric and Gynecologic Dermatology. 2nd ed. London, United Kingdom: Mosby; 2002: 39–44.

33. Shornick JK. Pregnancy dermatoses. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London, United Kingdom: Mosby; 2003: 425–432.

34. Lammert F, Marschall HU, Glantz A, et al. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33(6):1012–1021.

35. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467–474.

36. Bremmer M, Driscoll MS, Colgan R. The skin disorders of pregnancy. J Fam Pract. 2010;59(2):89–96.

37. Cohen LM, Kroumpouzos G. Pruritic dermatoses of pregnancy: to lump or to split? J Am Acad Dermatol. 2007;56(4):708–709.

38. Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther. 2008;21(1):32–41.

39. Crownover BK, Jamieson B, Mott TF. First- or second-generation antihistamines: which are more effective at controlling pruritus? J Fam Pract. 2004;53(9):742–744.

40. Finn AF Jr, Kaplan AP, Fretwell R, et al. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999;104(5):1071–1078.

41. Hägermark O, Wahlgren CF. Treatment of itch. Semin Dermatol. 1995;14(4):320–325.

42. Koblenzer CS. Itching and the atopic skin. J Allergy Clin Immunol. 1999;104(3 pt 2):S109–S113.



Copyright © 2011 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Download PDF
  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article